McNeel DG - Search Results

1

PD-1 or PD-L1 Blockade Restores Antitumor Efficacy Following SSX2 Epitope-Modified DNA Vaccine Immunization.

Rekoske BT, Smith HA, Olson BM, Maricque BB, McNeel DG. Rekoske BT, et al. Among authors: mcneel dg. Cancer Immunol Res. 2015 Aug;3(8):946-55. doi: 10.1158/2326-6066.CIR-14-0206. Epub 2015 Jun 3. Cancer Immunol Res. 2015. PMID: 26041735 Free PMC article.

2

Identification of T helper epitopes from prostatic acid phosphatase.

McNeel DG, Nguyen LD, Disis ML. McNeel DG, et al. Cancer Res. 2001 Jul 1;61(13):5161-7. Cancer Res. 2001. PMID: 11431355

3

Pilot study of an HLA-A2 peptide vaccine using flt3 ligand as a systemic vaccine adjuvant.

McNeel DG, Knutson KL, Schiffman K, Davis DR, Caron D, Disis ML. McNeel DG, et al. J Clin Immunol. 2003 Jan;23(1):62-72. doi: 10.1023/a:1021904432489. J Clin Immunol. 2003. PMID: 12645861 Clinical Trial.

4

Immune-based therapies for prostate cancer.

McNeel DG, Malkovsky M. McNeel DG, et al. Immunol Lett. 2005 Jan 15;96(1):3-9. doi: 10.1016/j.imlet.2004.06.009. Immunol Lett. 2005. PMID: 15585302 Review.

5

Plasmid DNA vaccine encoding prostatic acid phosphatase is effective in eliciting autologous antigen-specific CD8+ T cells.

Johnson LE, Frye TP, Chinnasamy N, Chinnasamy D, McNeel DG. Johnson LE, et al. Among authors: mcneel dg. Cancer Immunol Immunother. 2007 Jun;56(6):885-95. doi: 10.1007/s00262-006-0241-8. Epub 2006 Nov 11. Cancer Immunol Immunother. 2007. PMID: 17102977 Free PMC article.

6

Antibody and T-cell responses specific for the androgen receptor in patients with prostate cancer.

Olson BM, McNeel DG. Olson BM, et al. Among authors: mcneel dg. Prostate. 2007 Dec 1;67(16):1729-39. doi: 10.1002/pros.20652. Prostate. 2007. PMID: 17879963

7

Potentiating endogenous antitumor immunity to prostate cancer through combination immunotherapy with CTLA4 blockade and GM-CSF.

Fong L, Kwek SS, O'Brien S, Kavanagh B, McNeel DG, Weinberg V, Lin AM, Rosenberg J, Ryan CJ, Rini BI, Small EJ. Fong L, et al. Among authors: mcneel dg. Cancer Res. 2009 Jan 15;69(2):609-15. doi: 10.1158/0008-5472.CAN-08-3529. Cancer Res. 2009. PMID: 19147575 Clinical Trial.

8

Methods for constructing and evaluating antitumor DNA vaccines.

Olson BM, McNeel DG. Olson BM, et al. Among authors: mcneel dg. Methods Mol Biol. 2009;542:211-43. doi: 10.1007/978-1-59745-561-9_12. Methods Mol Biol. 2009. PMID: 19565905

9

Safety and immunological efficacy of a DNA vaccine encoding prostatic acid phosphatase in patients with stage D0 prostate cancer.

McNeel DG, Dunphy EJ, Davies JG, Frye TP, Johnson LE, Staab MJ, Horvath DL, Straus J, Alberti D, Marnocha R, Liu G, Eickhoff JC, Wilding G. McNeel DG, et al. J Clin Oncol. 2009 Sep 1;27(25):4047-54. doi: 10.1200/JCO.2008.19.9968. Epub 2009 Jul 27. J Clin Oncol. 2009. PMID: 19636017 Free PMC article. Clinical Trial.

10

HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase.

Olson BM, Frye TP, Johnson LE, Fong L, Knutson KL, Disis ML, McNeel DG. Olson BM, et al. Among authors: mcneel dg. Cancer Immunol Immunother. 2010 Jun;59(6):943-53. doi: 10.1007/s00262-010-0820-6. Epub 2010 Feb 6. Cancer Immunol Immunother. 2010. PMID: 20140431 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

138 results

Search Page